Product Information
ENOXAPARIN 300 MG/3 ML VIAL is a generic product labeled by Amphastar Pharmaceuticals, Inc., priced at $10.2663 per ML under NDC 00548560800. Its NADAC has been published 281 times since Jan 8, 2020.
FDA first approved this application on Mar 14, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/3mL
Manufacturer
Amphastar Pharmaceuticals, Inc.NDC
00548560800
Classification
Generic
Dosage Form
INJECTION
Route
INTRAVENOUS; SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
ENOXAPARIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA208600FDA Approved
3/14/2019
TE Code
AB
On Market Since
11/11/2019
Pharmacological Classes
Price Statistics
The NADAC for ENOXAPARIN 300 MG/3 ML VIAL has been published 281 times since Jan 8, 2020, and over the history we have for it it has declined 55.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.2663 per ML |
|---|---|
| All-time high | $23.2005 (Apr 15, 2020) |
| All-time low | $9.8758 (Jun 17, 2026) |
| 52-week high | $11.6405 |
| 52-week low | $9.8758 |
| Median price | $12.5053 |
| Average price | $13.0656 |
| Largest weekly change | -32.2% (Apr 22, 2020) |
| Weeks tracked | 281 |
| Tracking since | Jan 8, 2020 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ENOXAPARIN 300 MG/3 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for ENOXAPARIN 300 MG/3 ML VIAL, manufactured by Amphastar Pharmaceuticals, Inc., is $10.2663 per ML (NDC 00548560800), effective Aug 19, 2026.
How has the price of ENOXAPARIN 300 MG/3 ML VIAL changed over time?
Over the history we have for it, the NADAC for ENOXAPARIN 300 MG/3 ML VIAL has declined 55.7%. It has been tracked across 281 weekly CMS publications since Jan 8, 2020.
What are the highest and lowest recorded NADAC prices for ENOXAPARIN 300 MG/3 ML VIAL?
Since Jan 8, 2020, the NADAC for ENOXAPARIN 300 MG/3 ML VIAL has ranged from a low of $9.8758 (Jun 17, 2026) to a high of $23.2005 (Apr 15, 2020), with a median of $12.5053 per ML.
Are there cheaper alternatives to ENOXAPARIN 300 MG/3 ML VIAL?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ENOXAPARIN 300 MG/3 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures ENOXAPARIN 300 MG/3 ML VIAL?
ENOXAPARIN 300 MG/3 ML VIAL (NDC 00548560800) is labeled by Amphastar Pharmaceuticals, Inc., and CMS classifies it as a generic product.